Atlas Trials

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

Clinical trial NCT05027828 · RECRUITING

Trial details

NCT number
NCT05027828
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
High-grade Serous Ovarian CancerCirculating Tumor DNA
Start date
2021-09-01
Primary completion
2027-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.